Physician profile
Bennett So
NPI 1558349381
$1,208.01
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $638 · 2020: $264 · 2021: $306.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $221.74 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $182.86 | 2019-2021 | |
| Lilly USA, LLC | $178.52 | 2019-2021 | |
| Pfizer INC. | $101.38 | 2019-2021 | |
| Amgen INC. | $72.50 | 2019-2021 | |
| Novo Nordisk INC | $62.11 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.06 | 2019-2020 | |
| Amarin Pharma, INC. | $44.50 | 2019 | |
| Sanofi Pasteur INC. | $36.69 | 2019-2020 | |
| Allergan, INC. | $35.64 | 2019-2020 | |
| Abbvie INC. | $32.72 | 2021 | |
| Glaxosmithkline, LLC. | $31.95 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $31.32 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $25.66 | 2019-2021 | |
| Horizon Therapeutics Plc | $20.25 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $14.91 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $14.78 | 2021 | |
| Abbott Laboratories | $14.24 | 2019 | |
| Astellas Pharma US INC | $13.47 | 2019 | |
| Medtronic USA, INC. | $11.43 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.28 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bennett So listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.